Prognostic significance of BAF57 expression in patients with endometrial carcinoma

Histology and Histopathology

Volumn 27, Issue 5, 2012, Pages 593-599

  Kagami, S ^a   Kurita, T ^a   Kawagoe, T ^a   Toki, N ^a   Matsuura, Y ^a   Hachisuga, T ^a   Matsuyama, A ^a   Hashimoto, H ^a   Izumi, H ^a   Kohno, K ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

BAF57; Endometrial carcinoma; Estrogen receptor; P53

Indexed keywords

DNA BINDING PROTEIN; ESTROGEN RECEPTOR; NONHISTONE PROTEIN; PROTEIN P53; SMARCE1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER INVASION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, ESTROGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859316946     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F. and Shiekhattar R. (2000). BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257-265.
2. Cheng S.-W.G., Davies K.P., Yung E., Beltran R.J., Yu J., and Kalpana G.V. (1999). C-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 22, 102-105.
3. Garcia-Pedrero J.M., Kiskinis E., Parker M.G., and Belandia B. (2006). The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J. Biol. Chem. 281, 22656-22664.
4. Jia L., Liu Y., Yi X., Miron A., Crum CP., Kong B. and Zheng W. (2008). Endometrial glandular dysplasia with frequent p53 gene mutation: A genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin. Cancer Res. 14, 2263-2269.
5. Kiskinis E., Garcia-Pedrero J.M., Villaronga M.A., Parker M.G., and Belandia B. (2006). Identification of BAF57 mutations in human breast cancer cell lines. Breast Cancer Res. Treat. 98, 191-198.
6. Kounelis S., Kapranos N., Kouri E., Coppola D., Papadaki H., and Jones M. (2000). Immunohistochemical profile of endometrial adenocarcinoma: A study of 61 cases and review of the literature. Mod. Pathol. 13, 379-388.
7. Lee D., Kim J.W., Seo T., Hwang S.G., Choi E.J., and Choe J. (2002). SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J. Biol. Chem. 277, 22330-22337.
8. Link K.A., Balasubramaniam S., Sharma A., Comstock C.E.S., Godoy-Tundidor S., Powers N., Cao K.H., Haelens A., Claessens F., Revelo M.P. and Knudsen K.E. (2008). Targeting the BAF57 SWI/SNF subunit in prostate cancer: A novel platform to control androgen receptor activity. Cancer Res. 68, 4551-4558.
9. Muchardt C. and Yaniv M. (2001). When the SWI/SNF complex remodels...the cell cycle. Oncogene 20, 3067-3075.
10. Strober B., Dunaief J.L., Guha S. and Goff S. (1996). Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol. Cell Biol. 16, 1576-1583.
11. Trotter K.W. and Archer T.K. (2007). Nuclear receptors and chromatin remodeling machinery. Mol. Cell Endocrinol. 265-266, 162-167.
12. Uharcek P. (2008). Prognostic factors in endometrial carcinoma. J. Obstet. Gynaecol. Res. 34, 776-783.
13. Vogeistein B., Lane D. and Levine A.J. (2000). Surfing the p53 network. Nature 408, 307-310.
14. Wang L., Baiocchi R.A., Pal S., Mosialos G., Caligiuri M. and Sif S. (2005). The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol. Cell Biol. 25, 7953-7965.